Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: the role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104

Hostetter, 1981, Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation, Am J Physiol, 241, F85

Anderson, 1985, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest, 76, 612, 10.1172/JCI112013

Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, 1993, 10.1172/JCI112528

Mogensen, 1982, Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy, BMJ, 285, 685, 10.1136/bmj.285.6343.685

Parving, 1983, Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy, Lancet, i, 1175, 10.1016/S0140-6736(83)92462-5

Bjorck, 1992, Renal protective effect of enalapril in diabetic nephropathy, BMJ, 304, 339, 10.1136/bmj.304.6823.339

Parving, 1988, Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy, BMJ, 297, 1086, 10.1136/bmj.297.6656.1086

Lewis, 1993, The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004

Kasiske, 1993, Effects of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis, Ann Intern Med, 118, 129, 10.7326/0003-4819-118-2-199301150-00009

Weidmann, 1995, Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis, Nephrol Dial Transplant, 10, 39

Morelli, 1990, Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy, Diabetes, 39, 76, 10.2337/diacare.39.1.76

Remuzzi, 1993, Effect of low-dose enalapril on glomerular size selectivity in human diabetic nephropathy, J Nephrol, 6, 36

Remuzzi, 1990, Angiotensin converting-enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat, J Clin Invest, 85, 541, 10.1172/JCI114470

Remuzzi, 1995, Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury, Curr Opin Nephrol Hypertens, 4, 339, 10.1097/00041552-199507000-00009

Remuzzi, 1990, Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?, Kidney Int, 38, 384, 10.1038/ki.1990.217

Bertani, 1986, Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy, Kidney Int, 30, 488, 10.1038/ki.1986.212

Hirschberg, 1996, Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions, J Clin Invest, 98, 116, 10.1172/JCI118755

Eddy, 1994, Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions, J Am Soc Nephrol, 5, 1273, 10.1681/ASN.V561273

Kamper, 1992, Effect of enalapril on the progression of chronic renal failure: a randomised controlled trial, Am J Hypertens, 5, 423, 10.1093/ajh/5.7.423

Ihle, 1996, Angiotensin converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double blind trial, Am J Kidney Dis, 27, 489, 10.1016/S0272-6386(96)90158-4

Hannedouche, 1994, Randomized controlled trial of enalapril and β-blockers in non-diabetic chronic renal failure, BMJ, 309, 833, 10.1136/bmj.309.6958.833

Zucchelli, 1992, Long-term comparison between captopril and nifedipine in the progression of chronic renal insufficiency, Kidney Int, 42, 452, 10.1038/ki.1992.309

Maschio, 1996, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502

1991, A long-term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies, J Nephrol, 3, 193

Haybittle, 1971, Repeated assessments of results in clinical trials of cancer treatment, Br J Radiol, 44, 793, 10.1259/0007-1285-44-526-793

Erman, 1991, Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man, J Hypertens, 9, 1057, 10.1097/00004872-199111000-00012

Gaspari, 1995, Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal or impaired renal function, J Am Soc Nephrol, 6, 1, 10.1681/ASN.V62257

Rice, 1975, Improved biuret procedure for determination of urinary total proteins in clinical proteinuria, Clin Chem, 21, 398, 10.1093/clinchem/21.3.398

Parving, 1987, Effect of antihypertensive treatment on kidney function in diabetic nephropathy, BMJ, 294, 1443, 10.1136/bmj.294.6585.1443

Conover, 1987

Kalbfleish, 1980

Rossing, 1994, Reduction in albuminuria predicts diminished progression in diabetic nephropathy, Kidney Int, 45, 145

Apperloo, 1992, The initial antiproteinuric effect of antihypertensive treatment predicts the effect of treatment on long-term renal function outcome, J Am Soc Nephrol, 3, 279

Petterson, 1995, Blood pressure control, proteinuria, and the progression of renal disease, Ann Intern Med, 123, 754, 10.7326/0003-4819-123-10-199511150-00003

Remuzzi, 1991, Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy, Kidney Int, 39, 1267, 10.1038/ki.1991.160